Tottenham Acquisition I Limited

announcedU=S+W/2

CLNNSEC EDGARCIK: 0001822791|Norwich Investment Limited•Pharmaceuticals

Capital Structure & Economics

Trust SizeN/A

Unit Price$10.00

Warrant Coverage1/2

Sponsor Promote20%

Implied Equity Architecture

Public Trust Allocation	N/A
Sponsor At-Risk Capital	N/A
Total Underwriting Discount	N/A
Trust Per Unit (Implied)	$10.00
Sponsor Promote Allocation	20%

Deal Lifecycle

IPO PricedFeb 17, 2021

SearchingTarget Pending

Maturation Wall

N/A

Announced Target / M&A

Target CompanyClene Nanomedicine, Inc.
SectorPharmaceuticals
Announced Deal Size$542,540,558

Board & Officers

Robert Etherington⁽²⁾
CEO
Mark Mortenson⁽²⁾
Director
Robert Glanzman⁽²⁾
Director
Ted (Tae Heum) JeongDirector
Shalom Jacobovitz⁽²⁾
Director
Alison Mosca⁽²⁾
Director
Jonathon Gay⁽²⁾
Director
David J. Matlin⁽⁴⁾
Director
John Stevens⁽²⁾
Director
Reed Wilcox⁽²⁾
Director
Chidozie Ugwumba⁽²⁾
Director
Dr. Fiona CostelloDirector
Michael Hotchkin⁽²⁾
Director
Matthew Gardner⁽²⁾
Director

Advanced Structuring Terms

Target Sectors

Pharmaceuticals

Syndicate & Advisors

No syndicate data available.

Interactive Deal Modeling

Base financial constraints (Trust Size, Warrants, Promote) are pre-loaded into the calculation engines. Proceed to model implied dilution and advisory friction limits.

Dilution Cash Friction